510(k) · Cleared
ClearedRapid CTA 360
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Ischemaview · QAS Radiological Computer-Assisted Triage And Notification Software
Cleared on Jul 16, 2025 as substantially equivalent to K200941 (Ischemaview, Inc., 2020) after a 93-day review. Its family tree reaches back 4 generations to 2018. 1 later device descends from it.
- Decided
- Jul 16, 2025
- Review
- 93 days
- Class
- Class II
- Product code
- QAS
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 4 generations to DEN170073 (2018). 1 later device descends from it, 1 citing it directly.
- Root · 4 generations backDEN170073 ContaCTViz.Al, Inc. · 2018
- 3 generations backK180647 BriefCaseAidoc Medical, Ltd. · 2018
- 2 generations backK193087 Rapid ICHIschemaview Incorporated · 2020
- 1 generation backK200941 Rapid LVOIschemaview, Inc. · 2020
- This deviceK251151 Rapid CTA 360Ischemaview · 2025
- Descendant · cites it directly · 0 of its ownK261085 Rapid Vessel Occlusion (Rapid VO)iSchemaview · 2026
Most influential descendants
Showing 1 of 1 · See all- K261085Rapid Vessel Occlusion (Rapid VO)iSchemaview · 2026 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | DEN170073 | ContaCT | Viz.Al, Inc. | 2018 | — |
| −3 | K180647 | BriefCase | Aidoc Medical, Ltd. | 2018 | — |
| −2 | K193087 | Rapid ICH | Ischemaview Incorporated | 2020 | — |
| −1 | K200941 | Rapid LVO | Ischemaview, Inc. | 2020 | — |
| 0 (this device) | K251151 | Rapid CTA 360 | Ischemaview | 2025 | — |
| +1 | K261085 | Rapid Vessel Occlusion (Rapid VO) | iSchemaview | 2026 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QAS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QAS device
- #1 K203508 BriefCasescore 25.5 · 4 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K200941 | Rapid LVOSummary page 5…Devices: The iSchemaview Rapid CTA 360 Triage and Notification Module is claimed to be substantially equivalent to the legally marketed predicate, iSchemaView Rapid LVO (K200941); Rapid Neuro3d (K243350) is referenced as the technology used for vessel segmentation. Device Description: Rapid CTA 360 device… | 2020 |
| † | K243350 | Rapid Neuro3D | 2025 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K261085 | Rapid Vessel Occlusion (Rapid VO) | 2026 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 7 years and passes through 5 companies; a new generation was cleared every 1.7 years on median.
- None of the 4 ancestors has a recall.
- Of its descendants, K261085 (iSchemaview, 2026) has gone furthest, with 0 descendants of its own.
- 1 other device also cites its predicate K200941.
How does its category compare?
All QAS devicesQAS Radiological Computer-Assisted Triage And Notification Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.
FDA decisions per year · QAS
15in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · QAS
101in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · QAS
No recall names QAS since 2007.
Adverse event reports per year · QAS
No MAUDE report names QAS since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 3 | — | 0 | 0 |
| 2019 | 5 | 111 | 0 | 0 |
| 2020 | 12 | 112 | 0 | 0 |
| 2021 | 5 | 86 | 0 | 0 |
| 2022 | 15 | 116 | 0 | 0 |
| 2023 | 11 | 98 | 0 | 0 |
| 2024 | 12 | 136 | 0 | 0 |
| 2025 | 15 | 101 | 0 | 0 |
| 2026 | 11 | 104 | 0 | — |
What is it indicated for?
Rapid CTA 360 is a radiological computer aided triage and notification software indicated for use in the analysis of CTA adult head images. The device is intended to assist hospital networks and trained clinicians in workflow triage by flagging and communication of suspected positive Large and Medium Vessel Occlusion findings in head CTA images including the ICA (C1-C5), MCA (M1-M3), ACA, PCA, Basilar and Vertebral vascular segments. Rapid CTA 360 uses…
Read the full statement (198 words)
Rapid CTA 360 is a radiological computer aided triage and notification software indicated for use in the analysis of CTA adult head images. The device is intended to assist hospital networks and trained clinicians in workflow triage by flagging and communication of suspected positive Large and Medium Vessel Occlusion findings in head CTA images including the ICA (C1-C5), MCA (M1-M3), ACA, PCA, Basilar and Vertebral vascular segments.
Rapid CTA 360 uses an AI software algorithm to analyze images and highlight cases with suspected occlusion on a server or standalone desktop application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected LVO and MVO findings. Notifications include compressed preview images. These are meant for informational purposes only and are not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device.
The results of Rapid CTA 360 are intended to be used in conjunction with other patient information and based on professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K251151 · printed Nov 6, 2026
Cite this page
510(k) Report. “K251151: Rapid CTA 360.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K251151
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026